首次肾移植失败后再次移植的可及性与患者及移植物生存的关联:基于国家数据为分配政策提供信息
该观察性研究利用美国国家数据,分析有移植失败史的患者(n=27,459)与无移植失败史患者(n=1,426,677)接受死亡供者移植的可能性及移植结局。结果显示,移植失败患者接受移植的可能性更高(HR 1.16),但死亡删失的移植失败风险更高(HR 1.44),且移植后10年内需要额外肾脏替代治疗的时间更长。尽管移植物生存较差,移植与透析相比在有无移植失败史患者中均与相似的死亡风险降低相关。
要点
- 移植失败患者再次接受死亡供者移植的可能性高于无移植失败史患者(HR 1.16)。
- 移植失败患者死亡删失的移植失败风险更高(HR 1.44),10年内需额外肾脏替代治疗时间更长。
- 移植较透析降低死亡风险的幅度在有无移植失败史患者中临床相似。
核心结论
- 移植失败患者开始维持性透析后接受移植的可能性高于无移植史患者。
- 尽管死亡删失的移植物生存较差,移植与透析相比在有无移植失败史患者中均与相似的死亡风险降低相关。
研究设计与样本
- 观察性研究,基于国家数据,分析有移植失败史(n=27,459)与无移植失败史(n=1,426,677)的维持性透析患者。
- 比较新肾脏分配系统前后等待名单和死亡供者移植受者中移植失败者的比例。
- 在移植受者中评估移植物生存、移植后10年内需额外肾脏替代治疗的时间及移植与透析对死亡率的关联。
主要发现
- 等待名单候选人中移植失败者平均占14%,移植受者中平均占12%,新分配系统后未增加。
- 移植失败患者接受移植的可能性更高(HR 1.16;95%CI 1.12-1.20;P<0.001)。
- 移植失败患者死亡删失的移植失败风险更高(HR 1.44;95%CI 1.34-1.54;P<0.001)。
- 移植失败患者移植后10年内需额外肾脏替代治疗的时间更长(均值9.0个月;95%CI 5.4-12.6 vs 均值2.1个月;95%CI 1.5-2.7)。
- 移植 vs 透析与死亡率的关联在有移植失败史(HR 0.32;95%CI 0.29-0.35;P<0.001)和无移植失败史(HR 0.40;95%CI 0.39-0.41;P<0.001)患者中临床相似。
关键数值与推荐
- 移植失败患者接受移植的HR为1.16(95%CI 1.12-1.20;P<0.001)。
- 移植失败患者死亡删失移植失败的HR为1.44(95%CI 1.34-1.54;P<0.001)。
- 移植后10年内需额外肾脏替代治疗时间:移植失败组均值9.0个月(95%CI 5.4-12.6),无移植失败组均值2.1个月(95%CI 1.5-2.7)。
- 移植 vs 透析的死亡HR:有移植失败史0.32(95%CI 0.29-0.35;P<0.001),无移植失败史0.40(95%CI 0.39-0.41;P<0.001)。
临床怎么用
- 对于首次移植失败后开始透析的患者,应积极评估再次移植的可能性。
- 再次移植虽移植物生存较差,但仍与透析相比显著降低死亡风险,应合理分配移植资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients who have failed a transplant are at increased risk of repeat transplant failure. We determined access to transplantation and transplant outcomes in patients with and without a history of transplant failure. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this observational study of national data, the proportion of waitlisted patients and deceased donor transplant recipients with transplant failure was determined before and after the new kidney allocation system. Among patients initiating maintenance dialysis between May 1995 and December 2014, the likelihood of deceased donor transplantation was determined in patients with (n=27,459) and without (n=1,426,677) a history of transplant failure. Among transplant recipients, allograft survival, the duration of additional kidney replacement therapy required within 10 years of transplantation, and the association of transplantation versus dialysis with mortality was determined in patients with and without a history of transplant failure. RESULTS: The proportion of waitlist candidates (mean 14%) and transplant recipients (mean 12%) with transplant failure did not increase after the new kidney allocation system. Among patients initiating maintenance dialysis, transplant-failure patients had a higher likelihood of transplantation (hazard ratio [HR], 1.16; 95% confidence interval [95% CI], 1.12 to 1.20; P<0.001). Among transplant recipients, transplant-failure patients had a higher likelihood of death-censored transplant failure (HR, 1.44; 95% CI, 1.34 to 1.54; P<0.001) and a greater need for additional kidney replacement therapy required within 10 years after transplantation (mean, 9.0; 95% CI, 5.4 to 12.6 versus mean, 2.1; 95% CI, 1.5 to 2.7 months). The association of transplantation versus dialysis with mortality was clinically similar in waitlisted patients with (HR, 0.32; 95% CI, 0.29 to 0.35; P<0.001) and without transplant failure (HR, 0.40; 95% CI, 0.39 to 0.41; P<0.001). CONCLUSIONS: Transplant-failure patients initiating maintenance dialysis have a higher likelihood of transplantation than transplant-naïve patients. Despite inferior death-censored transplant survival, transplantation was associated with a similar reduction in the risk of death compared with treatment with dialysis in patients with and without a prior history of transplant failure.
引用
- Clark S, Kadatz M, Gill J, et al. Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival: An Analysis of National Data to Inform Allocation Policy. Clin J Am Soc Nephrol. 2019. PMID: 31337621. doi:10.2215/CJN.01530219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。